Walther Tabarelli1, Hugo Bonatti1, Dominique Tabarelli1, Miriam Eller1, Ludwig Müller1, Elfriede Ruttmann1, Cornelia Lass-Flörl1, Clara Larcher1, Christian Geltner1. 1. 1 Liechtensteinisches Landesspital, Vaduz, Liechtenstein ; 2 Department of Surgery, University of Maryland, Shore Health System, Easton, MD, USA ; 3 State Hospital Natters-Hochzirl, Innsbruck, Austria ; 4 Department of Cardiac Surgery, Innsbruck Medical University, Innsbruck, Austria ; 5 Medical University Innsbruck, Department Hygiene and Microbiology, Innsbruck, Austria ; 6 MB-LAB Mikrobiologisches Labor, Innsbruck, Austria ; 7 Kreisklinik Bad Reichenhall, Pulmonology, Bad Reichenhall, Germany.
Abstract
BACKGROUND: Due to the complex therapy and the required high level of immunosuppression, lung recipients are at high risk to develop many different long term complications. METHODS: From 1993-2000, a total of 54 lung transplantation (LuTx) were performed at our center. Complications, graft and patient survival of this cohort was retrospectively analyzed. RESULTS: One/five and ten-year patient survival was 71.4%, 41.2% and 25.4%; at last follow up (4/2010), twelve patients were alive. Of the 39 deceased patients, 26 died from infectious complications. Other causes of death were myocardial infarction (n=1), progressive graft failure (n=1), intracerebral bleeding (n=2), basilary vein thrombosis (n=1), pulmonary emboli (n=1), others (n=7). Surgical complication rate was 27.7% during the first year and 25% for the 12 long term survivors. Perioperative rejection rate was 35%, and 91.6% for the 12 patients currently alive. Infection incidence during first hospitalization was 79.6% (1.3 episodes per transplant) and 100% for long term survivors. Commonly isolated pathogens were cytomegalovirus (56.8%), Aspergillus (29.4%), RSV (13.7%). Other common complications were renal failure (56.8%), osteoporosis (54.9%), hypertension (45%), diabetes mellitus (19.6%). CONCLUSIONS: Infection and rejection remain the most common complications following LuTx with many other events to be considered.
BACKGROUND: Due to the complex therapy and the required high level of immunosuppression, lung recipients are at high risk to develop many different long term complications. METHODS: From 1993-2000, a total of 54 lung transplantation (LuTx) were performed at our center. Complications, graft and patient survival of this cohort was retrospectively analyzed. RESULTS: One/five and ten-year patient survival was 71.4%, 41.2% and 25.4%; at last follow up (4/2010), twelve patients were alive. Of the 39 deceased patients, 26 died from infectious complications. Other causes of death were myocardial infarction (n=1), progressive graft failure (n=1), intracerebral bleeding (n=2), basilary vein thrombosis (n=1), pulmonary emboli (n=1), others (n=7). Surgical complication rate was 27.7% during the first year and 25% for the 12 long term survivors. Perioperative rejection rate was 35%, and 91.6% for the 12 patients currently alive. Infection incidence during first hospitalization was 79.6% (1.3 episodes per transplant) and 100% for long term survivors. Commonly isolated pathogens were cytomegalovirus (56.8%), Aspergillus (29.4%), RSV (13.7%). Other common complications were renal failure (56.8%), osteoporosis (54.9%), hypertension (45%), diabetes mellitus (19.6%). CONCLUSIONS: Infection and rejection remain the most common complications following LuTx with many other events to be considered.
Entities:
Keywords:
Lung transplantation (LuTx); complications; cytomegalovirus; long term; outcome
Authors: Isabel P Neuringer; Peadar Noone; Rebecca K Cicale; Ken Davis; Robert M Aris Journal: Expert Rev Respir Med Date: 2009-08 Impact factor: 3.772
Authors: Jason D Christie; Leah B Edwards; Paul Aurora; Fabienne Dobbels; Richard Kirk; Axel O Rahmel; David O Taylor; Anna Y Kucheryavaya; Marshall I Hertz Journal: J Heart Lung Transplant Date: 2008-09 Impact factor: 10.247
Authors: Elfriede Ruttmann; Christian Geltner; Brigitte Bucher; Hanno Ulmer; Daniel Höfer; Herbert B Hangler; Severin Semsroth; Raimund Margreiter; Günther Laufer; Ludwig C Müller Journal: Transplantation Date: 2006-05-27 Impact factor: 4.939
Authors: Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett Journal: Clin Infect Dis Date: 2008-06-15 Impact factor: 9.079
Authors: Glen P Westall; Alexandra Michaelides; Trevor J Williams; Greg I Snell; Thomas C Kotsimbos Journal: Transplantation Date: 2003-06-27 Impact factor: 4.939
Authors: M Delgado; R Fernández; M Paradela; M De La Torre; D González; J A García; J M Borro Journal: Transplant Proc Date: 2008-11 Impact factor: 1.066
Authors: Anna Stjärne Aspelund; Helena Hammarström; Malin Inghammar; Hillevi Larsson; Lennart Hansson; Bertil Christensson; Lisa I Påhlman Journal: Am J Transplant Date: 2017-09-15 Impact factor: 8.086